We are a rare disease therapeutics company leading with science to make life-changing therapeutics available to patients with significant unmet needs. We involve key thought leaders, physicians, patients, care partners, and advocacy groups in all of our clinical and regulatory development strategies.

With a keen understanding that drug development often requires creative solutions, we have the insight and expertise to forge new pathways to success that others have missed. By following the data without bias, our transparent narratives and common-sense perspective have successfully overcome complex development challenges to make much-needed therapies available to patients.

Nimble and dauntless, we push boundaries beyond what is thought to be possible and advance new therapies that have the potential to bring meaningful improvement to patients’ lives.

Biotechnology

Life Sciences

Therapeutics

Zevra Therapeutics

Neil F. McFarlane

Louise Himmelstrup

Abbi M.

Laduane Clifton

Adrian Quartel

Daniel Gallo

Christopher M. Lauderback

Sven Guenther

R. Laduane Clifton

Joshua Schafer

Leadership Team

Clinical and Regulatory Affairs

Commercial Operations

Finance and Accounting

Research and Development

Teams at Zevra Therapeutics

Leadership Team

Clinical and Regulatory Affairs

Commercial Operations

Finance and Accounting

Research and Development